About: Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article published in 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1990 (uk) im Juli 1990 veröffentlichter wissenschaftlicher Artikel (de) article published in 1990 (en)
publication date	wds:Q56908472-08EF9458-078D-4CE9-A463-B75A14C6454E
publication date	1990-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56908472-11369EF5-1DC9-4210-AB6D-A6843E85C09C
language of work or name	English
exact match	wds:Q56908472-5196AA0D-50B6-41CE-AE82-C97652CA32A4
exact match	https://scigraph.springernature.com/pub.10.2165/00003088-199019010-00005
cites work	wds:Q56908472-0A3BADCA-05ED-4FE3-BFCF-B82352C74254 wds:Q56908472-0FD7A8C1-B71D-43A9-8CB0-721B59FE3FD0 wds:Q56908472-15B062ED-7FE2-4F20-B9E6-0689B99DF696 wds:Q56908472-1667395B-7050-4EF3-9F08-FA1B15A10909 wds:Q56908472-18CA0FA6-D722-4797-AB92-CB40DCEC001A wds:Q56908472-2EB71355-82A7-4D27-8453-8D45C9CB824B wds:Q56908472-306597C7-F980-421B-8892-39CCF71BD870 wds:Q56908472-356F2EFA-8428-40E7-B52E-5D2A7F5B8669 wds:Q56908472-424EB057-605A-4786-80AC-E26FF44E4A37 wds:Q56908472-60A35547-26C0-4796-9855-AE6BFB185857 wds:Q56908472-62F67208-E443-4874-8AAC-13BA7864C54E wds:Q56908472-6684F458-1C14-4684-8246-AE09519CCBD1 wds:Q56908472-77CA583F-2B0E-42B9-949D-CFAD868458ED wds:Q56908472-80FCB7BB-10FE-4ADA-91AD-F4A95C0CDE2A wds:Q56908472-86309082-6815-4794-9C7A-2957A98F0A85 wds:Q56908472-8AE6ED16-6966-447B-B12E-BCF22645C98D wds:Q56908472-9CB62E9E-D8F9-4815-946E-BD96864E4B06 wds:Q56908472-A12A0EE4-4B8E-4647-B8EC-0E92594BEF8E wds:Q56908472-AE9EEB0A-DF6C-495B-8737-CFDCB1AB5F18 wds:Q56908472-B232F232-9A97-4457-B1A0-30A064D00123 wds:Q56908472-B6F173EA-26CA-4890-8B2F-155AACA2E43B wds:Q56908472-CE93DAA7-967E-4CD1-B090-E024F70A51D4 wds:Q56908472-D000A59D-A234-4EB0-AFF4-4DB124A54FFF wds:Q56908472-D30142B7-0896-428F-B39A-150C3FBBBDEA wds:Q56908472-FE681730-7057-4ECB-B48A-F13FEF155EC2
cites work	Statistical moments in pharmacokinetics. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans Drug metabolite kinetics Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers Comparative oral pharmacokinetics of fleroxacin and pefloxacin In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones Steady-state levels of pefloxacin and its metabolites in patients with severe renal impairment Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis Pharmacokinetics of pefloxacin in renal insufficiency Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations The comparative pharmacokinetics of five quinolones Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by high-performance liquid chromatography with fluorescence detection Metabolism of fleroxacin in man In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone. In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens In-vitro activity of fleroxacin compared with three other quinolones The metabolism and pharmacokinetics of fleroxacin in healthy subjects Consequences of renal insufficiency on the hepatic clearance of some drugs
author name string	wds:Q56908472-0D8A0636-5DAF-43E3-83FC-3AAF7611CE27 wds:Q56908472-37DFBE03-CACB-47C2-9BAC-98D544B71670 wds:Q56908472-61237067-C11F-4AA0-B555-F9F899C3ED90 wds:Q56908472-734AE772-204B-4D01-80A7-A6ED9F1152C1 wds:Q56908472-78994AA9-BE85-4A9A-AEF5-86FFC86B63E9 wds:Q56908472-8CE9587C-0A53-4371-B248-49EA829732FA wds:Q56908472-8F93A207-5FFC-4E50-A082-8590AAF7669B wds:Q56908472-B8AA48CB-1A03-4CB7-BEBE-FAB7C030B8B2
author name string	J P Fillastre E Sultan B Moulin M Godin A Leroy M Dhib A M Taburet E Singlas
rdfs:label	Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis (en) Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis (nl)
skos:prefLabel	Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis (en) Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis (nl)
name	Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis (en) Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis (nl)
title	wds:Q56908472-1EF7AD4A-91B4-4B27-972F-44169955121E
title	Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis (en)
page(s)	wds:Q56908472-43E00F49-EECF-4BF4-A07D-0EEA43E41939
page(s)	67-79
instance of	wds:Q56908472-1938C38F-8A92-4522-BA94-08205E719AD3
instance of	scholarly article
PubMed ID	wds:Q56908472-CB5D54AC-7320-437C-AE26-F99576D3B4C5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2116256
PubMed ID	2116256
published in	wds:Q56908472-000FDA63-23BC-4D9A-88C7-0E6709C19C0F
published in	Clinical Pharmacokinetics
issue	wds:Q56908472-41C002B9-7E3B-4F8A-830B-A58CE43C795B
volume	wds:Q56908472-61E180C4-A96E-4B0F-A16E-6331963BA090
issue	1
volume	19
DOI	wds:Q56908472-0CF75E23-1FF7-49BA-AAB3-5C61C68A07CE
DOI	http://dx.doi.org/10.2165/00003088-199019010-00005

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software